Context Therapeutics Inc. Board of Directors

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Mr. Martin A. Lehr

Mr. Martin A. Lehr

Co-Founder, President, CEO & Director

Mr. Alex C. Levit Esq.

Mr. Alex C. Levit Esq.

Chief Legal Officer & Corporate Secretary

Mr. Christopher Beck M.B.A.

Mr. Christopher Beck M.B.A.

Senior Vice President of Operations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.